Metis Global Partners, LLC Teva Pharmaceutical Industries LTD Transaction History
Metis Global Partners, LLC
- $3.25 Billion
- Q4 2024
A detailed history of Metis Global Partners, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Metis Global Partners, LLC holds 13,697 shares of TEVA stock, worth $227,233. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,697
Previous 12,837
6.7%
Holding current value
$227,233
Previous $231,000
30.3%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
647Shares Held
585MCall Options Held
18.8MPut Options Held
7.13M-
Black Rock Inc. New York, NY43MShares$713 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$646 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$601 Million35.87% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$478 Million3.32% of portfolio
-
Exor Capital LLP London, X027.2MShares$451 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.4B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...